Key highlights this week include FDA approval of two highly-awaited drugs -- Sanofi SNY and Regeneron’s Dupixent and Roche’s RHHBY Ocrevus. Both drugs have blockbuster potential. Meanwhile, Mylan MYL got a complete response …
Yahoo!10mon
GlaxoSmithKline is in a tough spot. Chinese officials have accused the drugmaker of orchestrating a massive bribery and corruption scheme, putting it at risk of fines and legal action, major damage to its reputation, and loss of business in a …
Both strengths will be administered once-daily using Ellipta, a new dry powder inhaler (DPI). Darrell Baker, SVP & Head, GSK Global Respiratory Franchise, said, "For many years GSK has been focused on developing a portfolio of new …
An experimental drug for rheumatoid arthritis developed by Johnson & Johnson and GlaxoSmithKline slowed joint damage and improved symptoms of the disease, meeting the main goals of a large, late stage trial, according to data …
Mumbai: GlaxoSmithKline (GSK) will scrap the traditional appraisal system of its employees in favour of a new performance management mechanism, which includes regular dialogue and feedback. Called 'My Plan', the mechanism …
The new chief executive of GlaxoSmithKline (GSK) is kicking off her tenure with a move to offload the division which owns Maximuscle, a nutritional products brand favoured by elite athletes. Sky News has learnt that Emma Walmsley, who …
For the long line of Indian pharmaceutical companies knocking on the doors of the lucrative China market, the current unraveling of the vast domestic operations of British giant GlaxoSmithKline (GSK), amid an official probe into alleged …
Drug maker GlaxoSmithKline was fined $492 million on Friday for bribing doctors in China in the biggest such penalty ever imposed by a Chinese court. The court sentenced the company's former China manager, Briton Mark Reilly, and …
CBC3y
Cue sparklers. Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of $3 billion to …